|
Adult Treatment Panel III. Executive
summary of the third report of the National Cholesterol Education
Program (NCEP) expert panel on detection, evaluation, and
treatment of high blood cholesterol in adults (Adult Treatment
Panel III). JAMA 2001;285:2486-97.
Alberti KG, Gries FA, Jervell J, et
al. A desktop guide for the management of non-insulin-dependent
diabetes mellitus (NIDDM): an update. European NIDDM Policy
Group. Diabet Med 1994;11:899-909.
American Diabetes Association.
Clinical practice recommendations 2001. Diabetes Care 2001;24:S58-S61.
Brooks MM, Jones RH, Bach RG, et al.
Predictors of mortality from cardiac causes in the bypass
angioplasty revascularisation investigation (BARI) randomized
trial and registry. For the BARI investigators. Circulation
2000;13:2682-9.
European Arterial Risk Policy
Group on behalf of the International Diabetes Federation (European
Region). A strategy for arterial risk assessment and management
in type 2 (non-insulin-dependent) diabetes mellitus. Diabet
Med 1997;14:611-21.
Gray RP, Yudkin JS. Cardiovascular disease
in diabetes mellitus. In: Textbook of Diabetes. 2nd ed. Pickup
JC, Williams G (eds). Oxford: Blackwell Science Ltd, 1997;57.1-57.22.
Herlitz J, Malmberg K, Karlson BW,
et al. Mortality and morbidity during a five-year follow-up
of diabetics with myocardial infarction. Acta Med Scand 1988;224:31-8.
Jay RH, Betteridge DJ. The heart and macrovascular
disease in diabetes mellitus. In: Chronic complications of
diabetes. Pickup JC, Williams G (eds). Oxford: Blackwell Scientific
Publications, 1994;195-212.
Joseph T, Fajadet J, Jordan C, et al.
Coronary stenting in diabetics: immediate and mid-term clinical
outcome. Catheter Cardiovasc Interv 1999;47:279-84.
Kannel WB. Role of diabetes in cardiac
disease: conclusions from population studies. In: Diabetes
and the Heart. Zoneraich S (ed). Springfield: CC Thomas, 1978;97-112.
Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham Study. JAMA 1979;241:2035-8.
Kannel WB, McGee DL. Diabetes and cardiovascular
risk factors: the Framingham Study. Circulation 1979;59:8-13.
Kern MJ, Dupouy P, Drury JH, et al. Role
of coronary artery lumen enlargement in improving coronary
blood flow after balloon angioplasty and stenting: a combined
intravascular ultrasound Doppler flow and imaging study. J
Am Coll Cardiol 1997;29:1520-7.
Kiemeneji F, Serruys PW, Macaya C,
et al. Continued benefit of coronary stenting versus balloon
angioplasty: five-year clinical follow-up of Benestent-I trial.
J Am Coll Cardiol 2001;37:1598-603.
Kornowski R, Mintz GS, Kent KM, et
al. Increased restenosis in diabetes mellitus after coronary
interventions is due to exaggerated intimal hyperplasia. Circulation
1997;95:1366-9.
Lincoff AM. Potent complementary clinical
benefit of abciximab and stenting during percutaneous coronary
revascularisation in patients with diabetes mellitus: Results
of the EPISTENT trial. Am Heart J 2000;139:S46-S52.
Mak KH, Belli G, Ellis SG, et al. Subacute
stent thrombosis: evolving issues and current concepts. J
Am Coll Cardiol 1996;27:494-503.
Marks HH. Krall LP. Onset, course, prognosis
and mortality in diabetes mellitus. In: Joslin's Diabetes
Mellitus. 11th ed. Marble A, White P, Bradley RF, Krall LP
(eds). Philadelphia: Lea & Felbiger, 1971;209-54.
Muller DW, Ellis SG, Debowey DL, et
al. Quantitative angiographic comparison of the immediate
success of coronary angioplasty, coronary atherectomy and
endoluminal stenting. Am J Cardiol 1990;66:938-42.
Schofer J, Schluter M, Rau T, et al.
Influence of treatment modality on angiographic outcome after
coronary stenting in diabetic patients: a controlled study.
J Am Coll Cardiol 2000;35:1554-9.
Serruys PW, Unger F, Sousa JE, et al.
Comparison of coronary-artery bypass surgery and stenting
for the treatment of multivessel disease. N Engl J Med 2001;344:1117-24.
Silva JA, Ramee SR, White CJ, et al.
Primary stenting in acute myocardial infarction: Influence
of diabetes mellitus in angiographic results and clinical
outcome. Am Heart J 1999;138:446-55.
Suryapranata H, Ottervanger JP,
Nibbering E, et al. Long term outcome and cost-effectiveness
of stenting versus balloon angioplasty for acute myocardial
infarction. Heart 2001;85:667-71.
Takeuchi M, Himeno E. Does coronary
artery stenting following balloon angioplasty improve myocardial
fractional flow reserve? Cardiovasc Intervent Radiol 1998;21:459-63.
Van Belle E, Bauters C, Hubert E,
et al. Restenosis rates in diabetic patients: a comparison
of coronary stenting and balloon angioplasty in native coronary
vessels. Circulation 1997;96:1454-60.
Yudkin J, Hendra TJ. Vascular events
and diabetes: acute myocardial infarction and stroke. In:
International textbook of diabetes. Alberti KGMM, Keen HA,
de Fronzo RA (eds). Chichester: John Wiley & Sons Ltd,
1992;1185-212.
Previous
|
